title: Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization.
abstract: Human Herpesvirus 6 (HHV-6) is a ubiquitous virus with an estimated seroprevalence of 95% in the adult population. HHV-6 is associated with several neurologic disorders, including multiple sclerosis, an inflammatory demyelinating disease affecting the CNS. Animal models of HHV-6 infection would help clarify its role in human disease but have been slow to develop because rodents lack CD46, the receptor for cellular entry. Therefore, we investigated the effects of HHV-6 infections in a non-human primate, the common marmoset Callithrix jacchus. We inoculated a total of 12 marmosets with HHV-6A and HHV-6B intravenously and HHV-6A intranasally. Animals were monitored for 25 weeks post-inoculation clinically, immunologically and by MRI. Marmosets inoculated with HHV-6A intravenously exhibited neurologic symptoms and generated virus-specific antibody responses, while those inoculated intravenously with HHV-6B were asymptomatic and generated comparatively lower antibody responses. Viral DNA was detected at a low frequency in paraffin-embedded CNS tissue of a subset of marmosets inoculated with HHV-6A and HHV-6B intravenously. When different routes of HHV-6A inoculation were compared, intravenous inoculation resulted in virus-specific antibody responses and infrequent detection of viral DNA in the periphery, while intranasal inoculation resulted in negligible virus-specific antibody responses and frequent detection of viral DNA in the periphery. Moreover, marmosets inoculated with HHV-6A intravenously exhibited neurologic symptoms, while marmosets inoculated with HHV-6A intranasally were asymptomatic. We demonstrate that a marmoset model of HHV-6 infection can serve to further define the contribution of this ubiquitous virus to human neurologic disorders.
authors: Viral Immunology Section, Neuroimmunology Branch, NINDS/NIH, Bethesda, Maryland, United States of America.
authors: Emily
authors: E
authors: Leibovitch
authors: Jillian E
authors: JE
authors: Wohler
authors: Sheila M
authors: SM
authors: Cummings Macri
authors: Kelsey
authors: K
authors: Motanic
authors: Erin
authors: E
authors: Harberts
authors: María I
authors: MI
authors: Gaitán
authors: Pietro
authors: P
authors: Maggi
authors: Mary
authors: M
authors: Ellis
authors: Susan
authors: S
authors: Westmoreland
authors: Afonso
authors: A
authors: Silva
authors: Daniel S
authors: DS
authors: Reich
authors: Steven
authors: S
authors: Jacobson
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D001921:Brain / Q000473:pathology / Q000821:virology; D002144:Callithrix / Q000502:physiology*; D004279:DNA, Viral / Q000032:analysis; D004195:Disease Models, Animal; D015654:Herpesvirus 6, Human / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D009422:Nervous System Diseases / Q000175:diagnosis / Q000276:immunology* / Q000821:virology; D019349:Roseolovirus Infections / Q000175:diagnosis / Q000276:immunology / Q000821:virology; D013116:Spinal Cord / Q000473:pathology / Q000821:virology
chemical_list: D004279:DNA, Viral
references: Curr Infect Dis Rep. 2008 Jul;10(4):292-9
references: 18765102
references: J Immunol. 2008 Feb 1;180(3):1326-37
references: 18209026
references: J Gen Virol. 2011 Oct;92(Pt 10):2272-2280
references: 21697346
references: Int MS J. 2003 Apr;10(1):6-12
references: 12906764
references: J Med Virol. 2001 Jan;63(1):45-51
references: 11130886
references: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7440-4
references: 7638210
references: J Virol. 1996 Feb;70(2):1296-300
references: 8551599
references: Brain. 2005 Mar;128(Pt 3):516-27
references: 15659422
references: J Virol. 2005 Aug;79(15):9439-48
references: 16014907
references: Rev Med Virol. 2000 May-Jun;10(3):155-73
references: 10815027
references: PLoS Med. 2007 May;4(5):e180
references: 17535102
references: Lancet. 1988 May 14;1(8594):1065-7
references: 2896909
references: Ann Neurol. 1995 Apr;37(4):519-30
references: 7717689
references: J Clin Microbiol. 2007 Dec;45(12):3972-8
references: 17942643
references: J Infect Dis. 2007 Feb 1;195(3):450-4
references: 17205485
references: J Infect Dis. 2003 May 1;187(9):1377-87
references: 12717618
references: J Med Virol. 2010 Oct;82(10):1669-78
references: 20827763
references: Transpl Int. 2012 May;25(5):493-502
references: 22356254
references: Neuropathology. 2010 Feb 1;30(1):50-5
references: 19422536
references: Clin Microbiol Rev. 2006 Jan;19(1):80-94
references: 16418524
references: Mod Pathol. 2006 May;19(5):726-37
references: 16528368
references: Ann Neurol. 2000 Mar;47(3):306-13
references: 10716249
references: Science. 1986 Oct 31;234(4776):596-601
references: 2876520
references: N Engl J Med. 2005 Feb 24;352(8):768-76
references: 15728809
references: J Exp Med. 1990 Jun 1;171(6):1893-907
references: 1693653
references: J Med Virol. 1993 May;40(1):44-52
references: 8099945
references: Intervirology. 2003;46(5):257-69
references: 14555846
references: Nat Med. 1997 Dec;3(12):1394-7
references: 9396611
references: Epilepsia. 2008 Nov;49(11):1828-37
references: 18627418
references: Ann Neurol. 2009 Mar;65(3):257-67
references: 19334059
references: Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13734-9
references: 21825120
references: J Med Virol. 2005 Jan;75(1):76-85
references: 15543581
references: PLoS One. 2008 Apr 30;3(4):e2028
references: 18446218
references: Neurosciences (Riyadh). 2011 Jul;16(3):224-8
references: 21677611
references: Biochem J. 1998 Mar 15;330 ( Pt 3):1351-9
references: 9494106
references: Lancet Neurol. 2004 Oct;3(10):588-97
references: 15380155
references: J Virol. 1999 Oct;73(10):8040-52
references: 10482553
references: Clin Microbiol Rev. 1997 Jul;10(3):521-67
references: 9227865
references: J Neuropathol Exp Neurol. 2009 Apr;68(4):341-55
references: 19337065
references: Mult Scler. 2012 Jun;18(6):799-806
references: 22084489
references: Exp Brain Res. 1994;102(2):227-43
references: 7705502
references: Lancet. 1990 May 5;335(8697):1047-50
references: 1970369
references: J Neurovirol. 2002 Jun;8(3):250-6
references: 12053279
references: J Gen Virol. 1992 Jul;73 ( Pt 7):1673-7
references: 1321207
references: J Neurovirol. 2005 Aug;11(4):384-94
references: 16162481
references: J Virol. 1987 Oct;61(10):2951-5
references: 3041014
references: PLoS Pathog. 2009 Oct;5(10):e1000606
references: 19798430
references: Cell. 1999 Dec 23;99(7):817-27
references: 10619434
references: J Neuroimmune Pharmacol. 2011 Sep;6(3):341-53
references: 20700661
references: J Neurovirol. 2005 Apr;11(2):129-37
references: 16036791
references: Psychiatry Clin Neurosci. 2000 Oct;54(5):589-93
references: 11043811
references: J Infect Dis. 2001 Jan 1;183(1):130-3
references: 11076708
references: Semin Fetal Neonatal Med. 2012 Dec;17(6):336-40
references: 22871417
references: J Infect Dis. 2003 May 1;187(9):1365-76
references: 12717617
references: J Med Virol. 2006 Dec;78(12):1542-53
references: 17063514
references: Clin Microbiol Rev. 2005 Jan;18(1):217-45
references: 15653828
references: J Neurovirol. 1998 Oct;4(5):486-94
references: 9839646
references: J Clin Virol. 2006 Dec;37 Suppl 1:S27-32
references: 17276364
references: Expert Rev Mol Med. 1997 Nov 05;1997:1-17
references: 14585128
references: Brain Pathol. 2006 Jan;16(1):20-7
references: 16612979
references: J Med Virol. 2000 Sep;62(1):52-9
references: 10935989
references: J Infect Dis. 2000 Nov;182(5):1321-5
references: 11023456